CUE BIOPHARMA INC. - COMMON STOCK
1,1500
25-ноября-24 11:28:36
15 мин. задержка
Акции
+0,1300
+12,75%
Сегодняшний диапазон
1,0500 - 1,2431
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Cue Biopharma to Present at the Guggenheim I&I Spotlight Series
11 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the JMP Securities Life Sciences Conference
13 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Jefferies Healthcare Conference
01 июн 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
26 май 2022 16:00:00 Источник Nasdaq GlobeNewswire
-
11 май 2022 07:01:12 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Reports First Quarter 2022 Financial Results
10 май 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Upcoming Oppenheimer 32nd Annual Healthcare Conference
10 мар 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
02 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
15 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
26 янв 2022 15:01:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast for Ongoing CUE-101 Clinical Trials
20 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
05 янв 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Announces Appointment of Patricia Nasshorn as Chief Business Officer
15 дек 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at JMP Securities Hematology and Oncology Summit
06 дек 2021 07:00:03 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Piper Sandler 33rd Annual Healthcare Conference
22 ноя 2021 07:00:02 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
10 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
21 окт 2021 11:00:00 Источник Nasdaq GlobeNewswire
-
04 окт 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
28 сен 2021 07:00:02 Источник Nasdaq GlobeNewswire